Pre-Movers Stocks In Imitation: Apple Inc. (NASDAQ:AAPL), Galectin Therapeutics, Inc. (NASDAQ:GALT)

Apple Inc. (NASDAQ:AAPL) [Trend Analysis] knocking active thrust in leading trading session, shares an advance of 0.06% to 116.80 with around 2.56 Million shares have changed hands in this session. It appears Apple had a great holiday season when it came to sales of iPhone and iPad devices, while Samsung and Google did not fare so well. As per data by Flurry Analytics, Apple and Samsung together constituted 65 percent of the global device activations in the week leading up to Christmas Day and the start of Hanukkah.

Flurry Analytics reports that during the holiday period, 44 percent of phone and tablet activations were Apple’s iOS devices. In the same period, 21 percent of activations were Samsung devices. The market research firm said that while Samsung’s device activations were less than half those of Apple, the South Korean company saw a 1 percent increase in activations year over year. The stock is going forward its fifty-two week low with 31.93% and lagging behind from its 52-week high price with -1.09%.

Similar, the positive performance for the quarter recorded as 4.59% and for the year was 11.19%, while the YTD performance remained at 13.36%. AAPL has Average True Range for 14 days of 1.42.

Galectin Therapeutics, Inc. (NASDAQ:GALT) [Trend Analysis] retains strong position in active trade, as shares scoring -0.98% to $1.01 in a active trade session, while looking at the shares volume, around 28716 shares have changed hands in this session. Galectin Therapeutics Inc. (GALT) revealed that it has recently completed a private placement of its common stock, raising $3,000,000 in new funding. In a separate transaction, the Company also closed an additional sale of its Series B-3 preferred stock resulting in $1,008,000 of additional new proceeds.

In the placement of common stock, one existing investor and a new investor purchased 2,814,230 shares of common stock at above market price and received warrants for common stock exercisable at $5.00 per share.

The firm has institutional ownership of 18.40%, while insider ownership included 21.14%. GALT attains analyst recommendation of 3.30 with week’s performance of 9.68%. Investors looking further ahead will note that the Price to next year’s EPS is -7.40%.


About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Leave a Reply

Your email address will not be published. Required fields are marked *